A post-marketing database surveillance to investigate the risk of diagnosed peripheral neuropathy and optic nerve disorder events in MRSA patients treated with tedizolid or linezolid in Japan (MK-1986-047)

First published 14/01/2026

Last updated 14/01/2026

EU PAS number:

EUPAS1000000898

Study

Ongoing

Documents

Study protocol

Initial protocol

E_MK-1986-047_post-marketing database study_Peripheral neuropathy and optic nerve disorder_protocol_final redaction.pdf

English (1.7 MB - PDF) View document

Study results

Study report

Other information

Secondary tabs